Share
Market Research Report

CHRONIC SPONTANEOUS URTICARIA MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Segmentation
  • By Drug ClassMonoclonal antibodies (Xolair, Dupixent) · Antihistamines · and Phase 3 drugs (Ligelizumab, Remibrutinib)
  • By TypeBranded and Generic
  • By FormInjectable · Tablets · Capsules · and Syrup
  • By Route of AdministrationOral and Subcutaneous
  • By AgePediatric · Adult · and Geriatric
  • By Distribution ChannelHospital Pharmacies · Retail Pharmacies · and Online Pharmacies
  • By GeographyNorth America · Europe · Asia Pacific · Latin America · Middle East · and Africa
  • Published In31 Mar 2026
  • Report CodeCMI9407
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026 - 2033

  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations

  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Global Chronic Spontaneous Urticaria Market, By Drug Class
      • Global Chronic Spontaneous Urticaria Market, By Type
      • Global Chronic Spontaneous Urticaria Market, By Form
      • Global Chronic Spontaneous Urticaria Market, By Route of Administration
      • Global Chronic Spontaneous Urticaria Market, By Age
      • Global Chronic Spontaneous Urticaria Market, By Distribution Channel
      • Global Chronic Spontaneous Urticaria Market, By Region

  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Driver
    • Restraint
    • Opportunity
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
    • Product Launches/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Merger and Acquisition Scenario
    • Industry Trends

  4. Global Chronic Spontaneous Urticaria Market, By Drug Class, 2021-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Monoclonal antibodies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
        • Xoair
        • Dupixent
    • Antlihistamines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Phase 3 drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
        • Ligelizumab
        • Remibrutinib

  5. Global Chronic Spontaneous Urticaria Market, By Type, 2021-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Branded
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Generic
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

  6. Global Chronic Spontaneous Urticaria Market, By Form, 2021-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Injectable
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Tablets
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Capsules
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Syrup
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

  7. Global Chronic Spontaneous Urticaria Market, By Route of Administration, 2021-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Oral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Subcutaneous
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

  8. Global Chronic Spontaneous Urticaria Market, By Age, 2021-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Pediatric
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Adult
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Geriatric
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

  9. Global Chronic Spontaneous Urticaria Market, By Distribution Channel, 2021-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

  10. Global Chronic Spontaneous Urticaria Market, By Region, 2021 - 2033, Value (USD Mn)

    • Introduction
      • Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
      • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Age, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Age, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Age, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Age, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Age, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Age, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
        • South Africa
        • North Africa
        • Central Africa

  11. Competitive Landscape

    • Novartis AG
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Sanofi S.A
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Regeneron Pharmaceuticals Inc
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • GlaxoSmithKline plc
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Pfizer Inc
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Genentech Inc (Roche Group)
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Merck & Co Inc
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Johnson & Johnson Services Inc
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • AstraZeneca plc
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Bayer AG
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Teva Pharmaceutical Industries Ltd
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • AbbVie Inc
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Amgen Inc
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Sun Pharmaceutical Industries Ltd
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • UCB S.A
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies

  12. Analyst Recommendations

    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map

  13. References and Research Methodology

    • References
    • Research Methodology
    • About us

*Browse 32 market data tables and 28 figures on 'Chronic Spontaneous Urticaria Market' - Global forecast to 2033